Veko Enroko 50mg Tablet for Dogs and Cats, 10 Tablets

Broad-Spectrum Bactericidal Action Across Multiple Body Systems: Enroko Yum Tab 50 mg targets and eliminates a wide array of bacterial pathogens affecting the gut, lungs, urinary tract, reproductive system, skin, wounds, and ear canal. This versatility means a single prescription antibiotic can address multiple concurrent or secondary infections within one treatment course, reducing the need for multiple medications.

Unique DNA-Level Mechanism Ensures Complete Bacterial Eradication: Unlike bacteriostatic antibiotics that merely inhibit bacterial growth, Enrofloxacin is bactericidal it directly destroys the bacterial DNA, leading to irreversible cell death. This means your pet's infection is not merely suppressed but actively eliminated, reducing the risk of relapse and antibiotic resistance.

Extra-Palatable Protein-Flavoured "Yum" Tablet Formulation: Veko Care's proprietary protein-flavoured tablet technology transforms a challenging medication task into one that your pet may actively welcome. The enhanced palatability dramatically reduces administration stress for both pet and pet parent, improving treatment adherence and ensuring the full antibiotic course is completed.

Convenient Once-Daily Dosing in Most Cases: Enrofloxacin's pharmacokinetic profile characterised by rapid oral absorption, long half-life, and deep tissue distribution enables once-daily administration in many clinical scenarios. This simplifies your pet's medication routine and supports consistent therapeutic drug levels throughout the day.

Scored Tablet Design for Accurate, Weight-Based Dosing: Each Enroko Yum Tab is scored for easy, precise splitting, enabling your veterinarian to tailor the dose accurately to your pet's exact body weight. This is especially valuable for smaller dogs and cats where precise dosing is critical to both efficacy and safety.

Effective Against Mycoplasmal Infections: In addition to conventional bacterial pathogens, Enrofloxacin is one of the few oral antibiotics with proven efficacy against Mycoplasma spp. organisms that cause respiratory disease and urogenital infections and are notoriously resistant to many standard antibiotic classes.

Rapid Tissue Penetration for Fast-Acting Relief: Enrofloxacin is absorbed from the gastrointestinal tract and reaches therapeutic concentrations in target tissues rapidly, meaning your pet begins experiencing relief from the discomfort of bacterial infection sooner than with many slower-absorbing antibiotic alternatives.

Domestically Manufactured to International GMP Standards: Produced by Veko Care at their MIDC Ranjangaon, Pune facility accredited by WHO, APVMA (Australia), and US-EPA Enroko Yum Tab is manufactured under stringent quality controls that ensure consistent potency, purity, and safety in every tablet.

How to Use:

Enroko Yum Tab 50 mg must be administered strictly according to the prescription and dosing schedule provided by your veterinarian. The dose is calculated on the basis of your pet's body weight, and the scored tablet design allows for accurate halving or quartering as required.

The tablet may be given orally with or without food. Administering the tablet with a small meal is preferred as it can reduce the chance of gastrointestinal discomfort and leverages the palatability of the protein-flavoured formulation. Tablets should be swallowed whole where possible, though the scored tablet may be broken along the score line for accurate dosing as directed by your vet.

Storage Advice:

Veko Enroko Yum Tab 50 mg should be stored at a temperature below 30°C in a cool, dry place, away from direct sunlight and sources of heat and moisture. Do not freeze the tablets. Keep them in their original blister packaging until the point of use to protect the integrity of each tablet. Store out of reach of children and other pets at all times. Do not use Enroko Yum Tab after the expiry date printed on the packaging discard expired tablets in a responsible manner and in accordance with local pharmaceutical waste disposal guidelines.

About the Brand:

Veko Care Pvt. Ltd. was founded in 2018 and has since established itself as one of India's fastest-growing and most innovative dedicated veterinary pharmaceutical manufacturers, achieving a remarkable revenue CAGR of 128% within its first three years of commercial operation. The brand holds a world-class manufacturing facility in MIDC Ranjangaon, Pune, accredited by an impressive portfolio of international regulatory bodies including WHO GMP, APVMA (Australia), NDA Uganda, ZAMRA Zambia, and VMD Kenya with products exported to over 45 countries and more than 200 marketing authorisations secured globally. Veko Care's two dedicated FDA-compliant manufacturing units operate under the latest GMP++, PIC/S, and WHO guidelines, with separate facilities for oral and external preparations and two state-of-the-art analytical and instrumentation laboratories ensuring batch-to-batch consistency. In India, Veko Care operates with a pan-India sales and distribution network of over 50 team members, bringing its innovative veterinary formulations including its signature extra-palatable Yumm tablet range directly to companion animal practitioners and pet parents across the country. Veko Care's unwavering commitment to science-led, animal-first pharmaceutical innovation, backed by international quality credentials, aligns seamlessly with Animeal's commitment to offering only the most trusted and clinically sound products for your beloved companions. Discover Veko Care today.

Disclaimer:

Please note that while Veko Enroko Yum Tab 50 mg is formulated with pharmaceutical-grade Enrofloxacin IP 50 mg and is specifically indicated for use in dogs and cats, it is a prescription-only veterinary antibiotic and must not be obtained, dispensed, or administered without a valid prescription issued by a registered veterinary practitioner. This product must be administered by or under the direct supervision of a licensed veterinarian self-prescription and self-administration are unsafe and may result in serious harm to your pet. Enrofloxacin must not be used in puppies under 1 year of age or in large-breed dogs under 18 months, as it may damage developing articular cartilage during rapid growth phases; it must not be used in kittens under 8 weeks of age. Particular caution is required in cats, as exceeding the recommended dose may cause irreversible retinotoxicity leading to blindness always adhere strictly to the veterinarian-prescribed dose. This product must not be administered concurrently with chloramphenicol, macrolides, or tetracyclines; if your pet is receiving theophylline, inform your veterinarian as dose adjustment may be required. Animeal supports your pet's health and happiness journey but does not replace the advice of a qualified veterinary professional.